DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Neramexane is an investigational drug.
There have been 16 clinical trials for Neramexane. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2009.
The most common disease conditions in clinical trials are Tinnitus, Nystagmus, Pathologic, and Nystagmus, Congenital. The leading clinical trial sponsors are Merz Pharmaceuticals GmbH, Forest Laboratories, and [disabled in preview].
Recent Clinical Trials for Neramexane
|A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects||Merz Pharmaceuticals GmbH||Phase 1|
|Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen||Merz Pharmaceuticals GmbH||Phase 1|
|Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus||Merz Pharmaceuticals GmbH||Phase 3|